VENUS REMEDIES LTD. - 526953 - Board Meeting Outcome for Outcome Of Board Meeting Dated 9Th November 2023
This has reference to the meeting of Board of Directors held on 9th November 2023 inter alia considered and approved the Unaudited Financial Results for the period ended on 30th September 2023 along with Limited Review report. Unaudited Financial Results for the period ended on 30th September 2023 along with Limited Review report are enclosed herewith. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies Limited Secures the Reputable "Three Star Export House" certificate from the Government of India. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus earns prestigious FICCI Healthcare Award 2023 for pioneering ''Organ-on-a Chip research model. VENUS REMEDIES LTD. - 526953 - Board Meeting Intimation for Meeting Of Board Of Directors Is Scheduled To Be Held On 09Th November 2023.
VENUS REMEDIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 ,inter alia, to consider and approve This is to inform you that the meeting of Board of Directors is scheduled to be held on 09th November 2023 inter alia: 1. To consider and approve Unaudited Standalone and Consolidated Financial Results for the quarter ended on 30th September 2023. 2. Any other business with the permission of Chair. VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies granted martket authorization for Bleomycin 15000 IU in the United Kingdom. Venus Remedies secures REO certification, shares up
The shares were up by 0.39 per cent to 258.85 am on the BSE VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies earns prestigious REO certification from CII for the second consecutive year. Venus Remedies secures approval for chemotherapy drugs in Philippines, shares surge
Venus Remedies has already submitted dossiers to the Health Ministry of the Philippines government for 45 more marketing authorisations VENUS REMEDIES LTD. - 526953 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Venus Remedies Consolidates in ASEAN, gets marketing approval for six chemotherapy drugs from the Philippines.